NEW YORK (GenomeWeb News) – German firms SIRS-Lab and Analytik Jena today announced a collaboration focused on sepsis diagnostics.
Under the deal, AJ Innuscreen, a subsidiary of Analytik Jena, will provide SIRS-Lab a platform for the automated isolation of nucleic acids and associated reagents. The products from Analytik Jena are tailored for the fully automated extraction of DNA in whole blood samples. A clinical study is underway to validate a PCR-based test being developed, which "should create the conditions to start marketing our sepsis diagnostics very soon," said Barbara Staehelin, CEO of SIRS-Lab, in a statement.
Axel Kunz, manager of corporate communications for SIRS-lab added that the goal is to get a CE-IVD mark for the test.
Financial terms of the deal were not disclosed.
Both Analytik-Jena and SIRS-Lab are based in Jena, Germany. Analytik-Jena provides systems for analytic measurements. SIRS-Lab is a molecular diagnostics firm focused on sepsis and other life-threatening infections.